TGFBR1 and hepatocellular carcinoma: These SMAD complexes then translocate into the nucleus to control the transcription of many downstream target genes.[8, 9, 10] Accordingly, targeted compounds that inhibit TGFBR1 function have been developed to suppress HCC progression.